Clinical Trials
> Gastric/Esophageal Cancer


A Phase1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (Bladder, Colon, Gastric, Renal)


A Phase III, Randomized,Placebo Controlled Study Of ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) As Monotherapy And In Combination With Platinum Chemotherapy In Patients With Untreated Locally Advanced Or Metastatic Urothelial Carcinoma.


Phase III A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer.